Efficacy Study of AlphaBRAIN Administered Orally

Launched by ONNITS LABS, LLC · Apr 10, 2016

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Community dwelling and can provide informed consent.
• • MMSE score of ≥ 26.
• • Body Mass Index within two standard deviations of the norm.
• • Fluent in English.
• • Willing to complete all study assessments.
• • Adequate visual and auditory acuity to allow for neuropsychological testing.
• Exclusion Criteria:
• • MMSE score \< 26
• • Body Mass Index greater then two standard deviations from the norm.
• • Visual or Auditory disability which would interfere with neuropsychological testing.
• • No past diagnosis of Stroke, ADD/ADHD, Learning Disability or Cardiac Condition.
• • No current life threatening illnesses.
• • Not currently (past 60 days) taking antidepressants or other psychoactive medications.
• • Not currently taking any non-prescription cognitive enhancers (nutraceuticals or vitamins such as Ginko biloba.
• • No history of alcohol or drug or dependence as defined by the DSM-IV-TR.